Skip to Content

Join the 'Trazimera' group to help and get support from people like you.

Trazimera News

ACC: Statins Cut Heart Failure Risk in Early Breast Cancer Treatment

THURSDAY, March 26, 2020 – For women with early breast cancer receiving anthracyclines or trastuzumab, statin treatment is associated with a reduced risk for heart failure hospital visits, according...

FDA Approves Kanjinti (trastuzumab-anns), a Biosimilar to Herceptin

THOUSAND OAKS, Calif., June 13, 2019 /PRNewswire/ – Amgen (NASDAQ:AMGN) and Allergan plc (NYSE:AGN) today announced that the U.S. Food and Drug Administration (FDA) has approved Kanjinti...

Surgery May Boost Outcomes in Common Form of Advanced Breast Cancer

TUESDAY, April 2, 2019 – A new study may help resolve a longstanding debate around the impact of surgery for a common form of advanced breast cancer. The study found that mastectomy may indeed boost...

FDA Approves Trazimera (trastuzumab-qyyp), a Biosimilar to Herceptin

March 11, 2019 - Pfizer Inc. today announced the United States (U.S.) Food and Drug Administration (FDA) has approved Trazimera (trastuzumab-qyyp), a biosimilar to Herceptin® (trastuzumab),1 for the ...

Ask a Question

Want to post your own question to this support group? You'll need to first create an account with Drugs.com (or sign in to your existing account).

Further Information

Related Condition Support Groups

Breast Cancer, Metastatic, Breast Cancer, Breast Cancer - Adjuvant, Gastric Cancer

Trazimera Patient Information at Drugs.com